Progyny, Inc. (NASDAQ:PGNY) Receives Average Recommendation of “Hold” from Brokerages

Progyny, Inc. (NASDAQ:PGNY) has received an average recommendation of “Hold” from the thirteen research firms that are presently covering the stock, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year price objective among brokers that have issued a report on the stock in the last year is $24.82.

A number of analysts have weighed in on PGNY shares. Bank of America increased their price target on Progyny from $21.00 to $25.00 and gave the stock a “buy” rating in a report on Tuesday, February 11th. JPMorgan Chase & Co. raised their target price on Progyny from $17.00 to $23.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 28th. Finally, Canaccord Genuity Group boosted their price target on Progyny from $17.00 to $23.00 and gave the company a “hold” rating in a research note on Friday, February 28th.

Institutional Trading of Progyny

A number of hedge funds and other institutional investors have recently bought and sold shares of PGNY. Leibman Financial Services Inc. grew its holdings in shares of Progyny by 100.7% during the fourth quarter. Leibman Financial Services Inc. now owns 63,509 shares of the company’s stock valued at $1,096,000 after buying an additional 31,872 shares during the last quarter. Fort Washington Investment Advisors Inc. OH lifted its position in Progyny by 90.1% in the 4th quarter. Fort Washington Investment Advisors Inc. OH now owns 1,467,780 shares of the company’s stock valued at $25,319,000 after acquiring an additional 695,740 shares in the last quarter. Aurora Investment Counsel acquired a new position in Progyny during the 3rd quarter valued at about $1,280,000. Clear Harbor Asset Management LLC bought a new stake in Progyny during the 4th quarter worth approximately $989,000. Finally, Barclays PLC raised its stake in shares of Progyny by 530.4% in the third quarter. Barclays PLC now owns 706,157 shares of the company’s stock worth $11,835,000 after purchasing an additional 594,140 shares during the last quarter. Institutional investors own 94.93% of the company’s stock.

Progyny Stock Up 1.6 %

PGNY opened at $21.84 on Thursday. Progyny has a twelve month low of $13.39 and a twelve month high of $38.98. The company has a fifty day moving average of $22.01 and a 200-day moving average of $18.55. The stock has a market cap of $1.87 billion, a PE ratio of 37.66, a price-to-earnings-growth ratio of 2.39 and a beta of 1.41.

About Progyny

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.